RecruitingNCT06624865

Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors


Sponsor

Hospices Civils de Lyon

Enrollment

75 participants

Start Date

Nov 5, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of the study is to investigate the impact of the microenvironment on tumorigenesis of small intestinal neuroendocrine tumors often located in the terminal ileum, without identified driver mutations.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood and stool sampling for people with small-intestine neuroendocrine tumors. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood and stool sampling

Blood and stool sampling


Locations(1)

Edouard Herriot University Hospital

Lyon, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06624865